Glutamine as an essential amino acid for KRas-driven cancer cells

E Bernfeld, DA Foster - Trends in Endocrinology & Metabolism, 2019 - cell.com
Cancer cells consume glutamine, a nonessential amino acid (NEAA), at exceedingly high
rates to fulfill their energetic and biosynthetic requirements for proliferation. Glutamine plays …

Targeting the glutamine-arginine-proline metabolism axis in cancer

D Wang, J Duan, Y Guo, J Chen, T Chen… - Journal of Enzyme …, 2024 - Taylor & Francis
Metabolic abnormalities are an important feature of tumours. The glutamine-arginine-proline
axis is an important node of cancer metabolism and plays a major role in amino acid …

[HTML][HTML] Aspartate rescues S-phase arrest caused by suppression of glutamine utilization in KRas-driven cancer cells

D Patel, D Menon, E Bernfeld, V Mroz, S Kalan… - Journal of Biological …, 2016 - ASBMB
During G 1-phase of the cell cycle, normal cells respond first to growth factors that indicate
that it is appropriate to divide and then later in G 1 to the presence of nutrients that indicate …

[HTML][HTML] Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer

J Li, D Zhang, S Wang, P Yu, J Sun, Y Zhang… - Journal of Advanced …, 2024 - Elsevier
Introduction Baicalein, a bioactive component of Scutellaria baicalensis Georgi, has been
shown to promote apoptosis in non-small cell lung cancer cells. However, previous studies …

SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism

Z Chen, J Lin, S Feng, X Chen, H Huang… - OncoTargets and …, 2019 - Taylor & Francis
Background SIRT4, a protein localized in the mitochondria, is one of the least characteristic
members of the sirtuin family. It is known that SIRT4 has deacetylase activity and plays a role …

Anticonvulsant action of a selective phosphatidylinositol-3-kinase inhibitor LY294002 in pentylenetetrazole-mediated convulsions in zebrafish

AG Mazumder, S Kumari, D Singh - Epilepsy research, 2019 - Elsevier
The role of PI3K/AKT/mTOR signalling pathway has been widely deciphered in
pathogenesis of epilepsy. LY294002 is a selective inhibitor of phosphatidylinositol-3-kinase …

[HTML][HTML] Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis

N Sun, Y Liang, Y Chen, L Wang… - International …, 2019 - spandidos-publications.com
Abstract Changes in metabolism are common phenomena in tumors. Glutamine (Gln) has
been documented to play a critical role in tumor growth. In this study, we aimed to to explore …

[HTML][HTML] Synthetic lethality in KRas-driven cancer cells created by glutamine deprivation

S Mukhopadhyay, M Saqcena, DA Foster - Oncoscience, 2015 - ncbi.nlm.nih.gov
Oncogenic KRas mutations are present in about 30% of all human cancers and in more than
90% of pancreatic cancers. KRas-driven cancers have been largely resistant to therapeutic …

[HTML][HTML] Tumour growth and immune evasion as targets for a new strategy in advanced cancer

A Nicolini, P Ferrari, G Rossi… - Endocrine-Related …, 2018 - erc.bioscientifica.com
It has become clearer that advanced cancer, especially advanced breast cancer, is an
entirely displayed pathological system that is much more complex than previously …

5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells

S Mukhopadhyay, A Chatterjee, D Kogan, D Patel… - Cell Cycle, 2015 - Taylor & Francis
mTOR–the mammalian/mechanistic target of rapamycin–has been implicated as a key
signaling node for promoting survival of cancer cells. However, clinical trials that have …